Features predicting colchicine efficacy in treatment of children with undefined systemic autoinflammatory disease: A retrospective cohort study

• Mariana Correia Marque,
• Buğra Han Egeli ,
• Holly Wobma ,
• Claudio Ribeiro,
• Edwin Anderson,
• Jonathan S. Hausmann,
• Fatma Dedeoğlu

Affiliations

Mariana Correia Marque

Pediatric Rheumatology Division, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, United States

Buğra Han Egeli

Program in Rheumatology, Division of Immunology, Boston Children’s Hospital, Boston, MA, United States; Division of Paediatrics, Children’s Hospital of Los Angeles, University of Southern California, Los Angeles, CA, United States

Holly Wobma

Program in Rheumatology, Division of Immunology, Boston Children’s Hospital, Boston, MA, United States

Claudio Ribeiro

Program in Rheumatology, Division of Immunology, Boston Children’s Hospital, Boston, MA, United States

Edwin Anderson

Program in Rheumatology, Division of Immunology, Boston Children’s Hospital, Boston, MA, United States

Jonathan S. Hausmann

Program in Rheumatology, Division of Immunology, Boston Children’s Hospital, Boston, MA, United States; Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Boston, MA, United States

Fatma Dedeoğlu

Program in Rheumatology, Division of Immunology, Boston Children’s Hospital, Boston, MA, United States